DYNAVAX TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 14 rows in 2011. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-06-01: Reporting owner CANO FRANCIS; Form 4; Security Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2011-06-01: Reporting owner Plotkin Stanley A; Form 4; Security Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2011-06-01: Reporting owner Phillips Peggy V; Form 4; Security Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2011-06-01: Reporting owner ORONSKY ARNOLD L; Form 4; Security Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-06-01 | CANO FRANCIS Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $2.55 exercise price | 2011-06-03 | |
| 2011-06-01 | Plotkin Stanley A Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $2.55 exercise price | 2011-06-03 | |
| 2011-06-01 | Phillips Peggy V Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $2.55 exercise price | 2011-06-03 | |
| 2011-06-01 | ORONSKY ARNOLD L Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $2.55 exercise price | 2011-06-03 | |
| 2011-06-01 | GILBERT DENISE Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $2.55 exercise price | 2011-06-03 | |
| 2011-06-01 | CARSON DENNIS Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $2.55 exercise price | 2011-06-03 | |
| 2011-06-01 | KISNER DANIEL L Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $2.55 exercise price | 2011-06-03 | |
| 2011-06-01 | KESSEL MARK Director, 10% Owner | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $2.55 exercise price | 2011-06-03 | |
| 2011-01-06 | COFFMAN ROBERT Officer (Chief Scientific Officer & VP) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $3.14 exercise price | 2011-01-07 | |
| 2011-01-06 | DINA DINO Director, Officer (CEO and Director) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +750,000 750,000 owned after | $3.14 exercise price | 2011-01-07 | |
| 2011-01-06 | JANOWICZ ZBIGNIEW Officer (CEO Dynavax Europe) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $3.14 exercise price | 2011-01-07 | |
| 2011-01-06 | MARTIN J TYLER Director, Officer (President, CMO & Director) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +550,000 550,000 owned after | $3.14 exercise price | 2011-01-07 | |
| 2011-01-06 | Lew Jennifer Officer (VP, Finance & PAO) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +300,000 300,000 owned after | $3.14 exercise price | 2011-01-07 | |
| 2011-01-06 | OSTRACH MICHAEL S Officer (VP, CBO, and General Counsel) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +250,000 250,000 owned after | $3.14 exercise price | 2011-01-07 |